Antoine Rachas
Biographic Data
| ID | 5539725 |
|---|---|
| NAME | Antoine Rachas |
| GIVEN NAMES | Antoine |
| FAMILY NAME | Rachas |
| SIGNATURE | RACHAS A |
| AFFILIATIONS | l'Assurance Maladie |
| ORCID | 0000-0001-9226-9071 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Estimating years of life lost due to premature mortality at regional level in France in 2017, using a probabilistic redistribution approach
We quantified the full mortality burden for the first time in France at regional level, based on a new probabilistic redistribution method developed by researchers from Sciensano before COVID-19 pandemic. These estimates are important for future investigations on the contribution of social inequalities and risk factors to all-cause mortality in France with a focus on regional differences
Outcomes associated with antidepressant treatment according to the number of prescriptions and treatment changes
Considering treatment changes is critical when using administrative claims database to examine the long-term psychiatric outcomes of antidepressant treatments in real-life settings
The Economic Burden of Disease in France From the National Health Insurance Perspective
BACKGROUND: Identifying the most frequently treated and the costliest health conditions is essential for prioritizing actions to improve the resilience of health systems. OBJECTIVES: Healthcare Expenditures and Conditions Mapping describes the annual economic burden of 58 health conditions to prepare the French Social Security Funding Act and the Public Health Act. DESIGN: Annual cross-sectional study (2015-2019) based on the French national heal…
No prominent works on this page.
Outcomes associated with antidepressant treatment according to the number of prescriptions and treatment changes
Considering treatment changes is critical when using administrative claims database to examine the long-term psychiatric outcomes of antidepressant treatments in real-life settings
The Economic Burden of Disease in France From the National Health Insurance Perspective
BACKGROUND: Identifying the most frequently treated and the costliest health conditions is essential for prioritizing actions to improve the resilience of health systems. OBJECTIVES: Healthcare Expenditures and Conditions Mapping describes the annual economic burden of 58 health conditions to prepare the French Social Security Funding Act and the Public Health Act. DESIGN: Annual cross-sectional study (2015-2019) based on the French national heal…
Estimating years of life lost due to premature mortality at regional level in France in 2017, using a probabilistic redistribution approach
We quantified the full mortality burden for the first time in France at regional level, based on a new probabilistic redistribution method developed by researchers from Sciensano before COVID-19 pandemic. These estimates are important for future investigations on the contribution of social inequalities and risk factors to all-cause mortality in France with a focus on regional differences
Medicine (3 works) · Environmental health (2 works) · Global Health Care Issues (2 works) · Internal Medicine (2 works) · Public health (2 works) · Antidepressant (1 work) · Biostatistics (1 work) · Cohort (1 work) · Cohort study (1 work) · Confidence interval (1 work)